NeuroOne Medical Technologies Corporation (NMTC) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.
The consensus price target is $3.00, representing an upside of 311% from the current price $0.73.
Analysts estimate Earnings Per Share (EPS) of $-0.41 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.46 vs est $-0.41 (missed -12.2%). 2025: actual $-0.09 vs est $-0.12 (beat +21.7%). Analyst accuracy: 81%.
NMTC Stock — 12-Month Price Forecast
$3.00
▲ +310.96% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for NeuroOne Medical Technologies Corporation, the price target is $3.00.
The average price target represents a +310.96% change from the last price of $0.73.
NMTC Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to NeuroOne Medical Technologies Corporation in the past 3 months
EPS Estimates — NMTC
81%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.46
vs Est –$0.41
▼ 10.9% off
2025
Actual –$0.09
vs Est –$0.12
▲ 27.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — NMTC
57%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.006B
▼ 59.3% off
2025
Actual $0.012B
vs Est $0.009B
▲ 26.4% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
